# Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-safety-and-genetic-analysis-of-furmonertinib-ast2818-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuankai Shi,Xingsheng Hu,Shucai Zhang,Dongqing Lv,Lin Wu,Qitao Yu,Yiping Zhang,Li Liu,Xiang Wang,Ying Cheng,Zhiyong Ma,Hongrui Niu,Dong Wang,Jifeng Feng,Cheng Huang,Chunling Liu,Hui Zhao,Jingzhang Li,Xiaodong Zhang,Yong Jiang,Chuan Gu |
| Citations | 124 |
| DOI | 10.1016/s2213-2600(20)30455-0 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3150444504 |
| PMID | 33780662 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Xingsheng Hu](https://scholariq.org/researchers/xingsheng-hu/)
- [Dong Wang](https://scholariq.org/researchers/dong-wang/)

## Paper journal

- [The Lancet Respiratory Medicine](https://scholariq.org/journals/the-lancet-respiratory-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.